BOBCARE and Baodao Obstetrics & Gynecology Hospital Announce Strategic Collaboration to Advance Fertility Healthcare

Recently, Beibeike and Beijing Baodao Maternity Hospital entered into a strategic partnership by signing the “Framework Agreement on Strategic Cooperation in Internet Healthcare.”

BeiBeike, an internet healthcare platform product, offers international assisted reproductive services designed to help a broad range of infertility patients understand the most advanced assisted reproductive technologies worldwide and share high-quality global medical resources. By leveraging online consultations and offline referral services, the platform eliminates waiting times at medical institutions, making treatment more convenient.

It is understood that Beibeike currently offers comprehensive assistance services for international assisted reproductive medical care, preconception diagnosis and treatment, and remote consultations at its preconception care centers. Following the establishment of a partnership with Formosa Woman and Children’s Hospital, patients can use the Beibeike platform to select and consult with various fertility specialists from Formosa Woman and Children’s Hospital based on their individual pathological conditions, and conveniently choose from a range of assisted reproduction service packages offered by the hospital.

Beijing Baodao Maternity Hospital is the first international high-end maternity hospital established through Beijing-Taiwan cooperation. Its Reproductive Medicine Center has been approved by the National Ministry of Health to perform artificial insemination procedures. The hospital offers reproductive services in China, including treatments for infertility and artificial insemination, achieving progress in both research and clinical practice. Earlier this year, the hospital successfully completed its first case of artificial insemination resulting in fraternal twins of opposite sexes (a "dragon-phoenix twin" pregnancy).

According to the latest data, China’s infertility rate has risen from 3% two decades ago to 12%, affecting over 40 million people to date. How to promptly address their challenges hinges critically on the allocation of medical resources. Shi Lei, CEO of Beibeike, stated that through a win-win partnership with Baodao Maternity Hospital, both parties will leverage their respective strengths, align with the development trend of “Internet + Healthcare,” expand access to assisted reproductive technology (ART) resources, and build a comprehensive ART health platform to provide all-around fertility assistance services to families struggling with infertility.

Shi Lei, Founder and CEO of Beibeike, stated that the company’s upcoming mission is to platformize mobile reproductive healthcare. By fully leveraging an open and collaborative strategy, Beibeike aims to build a patient-centric, end-to-end health and fertility assistance service platform. The company will continue to enhance the efficiency of assisted reproductive technology (ART) through the connectivity of mobile internet, thereby improving the landscape of fertility care in China.

Beibeike, since its launch last August, has successfully established preconception care centers in Beijing, Zhengzhou, Jinan, Guangzhou, and other cities. It has forged strong partnerships with leading medical institutions and research institutes, including Peking University Third Hospital, Tsinghua University, and the Chinese Center for Disease Control and Prevention, and has certified thousands of reproductive and obstetric-gynecologic physicians.